Dirk Thye - Aug 8, 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role: Chief Executive Officer, Director
Signature: /s/ Dirk Thye
Stock symbol: QNCX
Transactions as of: Aug 8, 2023
Transactions value $: $99,200
Form type: 4
Date filed: 8/9/2023, 06:23 PM
Previous filing: Feb 2, 2023
Next filing: Aug 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	QNCX	Common Stock	Purchase	$99.2K	+80K	+28.48%	$1.24	361K	Aug 8, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.